Immunoprecipitation of EGFR and HER3 following HER2 pull down in SKBr3, BT474 and BT474 Clone 5
centrifuged at 13,000 x g for 10 min at 4 °C and the supernatant collected. Immunoprecipitation was performed using published protocol (58) adapted and outlined below.
Generation of IP beads:
anti-HER2 mAb 7C2 (BSA/glycerol free) was purchased from Insight Biotechnology (Wembley, UK) and diluted to 400 µg/mL in 0.4 M Sodium Citrate, 0.1M Sodium HEPES, pH7.5. All 100 µg 7C2 was added to 5 mg Ultralink Biosupport (Fisher Scientific) and allowed to react for a minimum of 3 hr at room temperature under constant rotation. 7C2 beads were pelleted at 1,200 x g for 5 min and the supernatant removed. To both 7C2 beads and 5 mg control beads 10X the bead swell volume (10xSV) of 2M glycine in PBS was added and the solution allowed to react for 3 hr at room temperature under rotation. 7C2 and control beads were washed by pelleting (1,200 x g, 5 min) the beads and resuspended in 10xSV PBS for 15 min at room temperature under rotation. This was followed by further washes in 10xSV 1M NaCl, and two 10xSV PBS washes.
The beads were finally resuspended in 200 µL PBS and kept at 4°C for a maximum of 24 hr.
Immunoprecipitation using Ultralink Biosupport beads: 100 µg of cell lysate was incubated with 15 µL of 7C2 or control beads in a final volume of 200 µL lysis buffer overnight at 4 °C under constant rotation. The beads were pelleted at 1,200 x g for 5 min and the pellet was washed twice with 500 µL lysis buffer. The final pellet was resuspended in 15 µL PBS prior to adding SDS loading buffer containing DTT (5 µL). The sample was boiled for 4 min at 96 °C before being separated on a 7.5% SDS-PAGE gel, transferred to PDVF membranes and probed for EGFR, HER3 and finally HER2 as per the method section. and β-tubulin. C) Band intensities were quantified using ImageJ software and converted to graphs in Excel. The
